Preferences on advance care planning and end-of-life care in patients hospitalized for heart failure.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
12 2021
Historique:
revised: 07 07 2021
received: 28 01 2021
accepted: 11 08 2021
pubmed: 5 9 2021
medline: 22 3 2022
entrez: 4 9 2021
Statut: ppublish

Résumé

Early engagement in advance care planning (ACP) is recommended in heart failure (HF) management. We investigated the preferences of patients with HF regarding ACP and end-of-life (EOL) care, including their desired timing of ACP initiation. Data were collected using a 92-item questionnaire survey, which was directly distributed to hospitalized patients by dedicated physicians and nurses in a university hospital setting. One-hundred eighty-seven patients agreed to participate (response rate: 92.6%), and 171 completed the survey [valid response rate: 84.7%; men: 67.3%; median age: 73.0 (63.0-81.0) years]. Logistic regression analyses were conducted to identify the predictors of positive attitudes towards ACP. Most recognized ACP as important for their care (n = 127, 74.3%), 48.1% stated that ACP should be initiated after repeated HF hospitalizations in the past year, and 29.0% preferred ACP to begin during the first or second HF hospitalization. Only 21.7% of patients had previously engaged in ACP conversations during HF management. Positive attitudes towards ACP were associated with lower depressive symptoms [two-item Patient Health Questionnaire; odds ratio (OR): 0.75, 95% confidence interval (CI): 0.61-0.92, P-value: 0.006], marriage (OR: 2.53, 95% CI: 1.25-5.12, P-value: 0.010), and a high educational level (OR: 2.66, 95% CI: 1.28-5.56, P-value: 0.009), but not with severity of HF (represented by Seattle Heart Failure Model risk score). Regarding EOL care, while 'Saying what one wants to tell loved ones' (83.4%), 'Dying a natural death' (81.8%), and 'Being able to stay at one's favorite place' (75.6%) were the three most important factors for patients, preferences for 'Receiving sufficient treatment' (56.5%) and 'Knowing what to expect about future condition' (50.3%) were divergent. Despite patients' preferences for ACP conversations, there was a discrepancy between preference and engagement in ACP among patients hospitalized for HF. Patients' preferences regarding EOL care may differ; physicians need to consider the appropriate ACP approach to align with patients' care goals.

Identifiants

pubmed: 34480526
doi: 10.1002/ehf2.13578
pmc: PMC8712895
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5102-5111

Informations de copyright

© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

J Adv Nurs. 2008 May;62(4):470-8
pubmed: 18373613
Heart Vessels. 2019 Nov;34(11):1777-1788
pubmed: 31134379
J Am Coll Cardiol. 2017 Oct 10;70(15):1919-1930
pubmed: 28982506
Palliat Med. 2018 Dec;32(10):1539-1551
pubmed: 30234421
J Card Fail. 2021 Mar;27(3):318-326
pubmed: 33171293
J Am Coll Cardiol. 2019 Oct 15;74(15):1966-2011
pubmed: 31526538
Psychooncology. 2016 Apr;25(4):362-86
pubmed: 26387480
JAMA Intern Med. 2019 Jun 1;179(6):751-759
pubmed: 30870563
N Engl J Med. 2019 Oct 24;381(17):1603-1606
pubmed: 31644843
J Card Fail. 2019 Jul;25(7):561-567
pubmed: 30099192
ESC Heart Fail. 2018 Dec;5(6):1165-1172
pubmed: 30264449
J Pain Symptom Manage. 2015 Jul;50(1):38-47.e3
pubmed: 25656327
ESC Heart Fail. 2021 Dec;8(6):5102-5111
pubmed: 34480526
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
Circulation. 2012 Apr 17;125(15):1928-52
pubmed: 22392529
JAMA Intern Med. 2014 Jul;174(7):1085-92
pubmed: 24861560
Palliat Med. 2002 Mar;16(2):141-50
pubmed: 11969145
J Card Fail. 2017 Nov;23(11):821-825
pubmed: 28842378
J Pain Symptom Manage. 2008 May;35(5):486-98
pubmed: 18358685
J Am Coll Cardiol. 2019 Apr 16;73(14):1827-1845
pubmed: 30975301
Health Qual Life Outcomes. 2010 Jan 28;8:13
pubmed: 20109189
Circulation. 1993 Jul;88(1):107-15
pubmed: 8319323
Cardiovasc Res. 2020 Jan 1;116(1):12-27
pubmed: 31386104
J Pain Symptom Manage. 2019 Nov;58(5):891-898
pubmed: 31404639
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Eur J Heart Fail. 2018 Dec;20(12):1763-1765
pubmed: 30295978
BMJ. 2010 Mar 23;340:c1345
pubmed: 20332506
JACC Heart Fail. 2015 Feb;3(2):122-6
pubmed: 25543973
Palliat Med. 2014 Sep;28(8):1000-25
pubmed: 24651708
N Engl J Med. 2019 Jan 31;380(5):408-409
pubmed: 30699322
Gen Hosp Psychiatry. 2018 May - Jun;52:64-69
pubmed: 29698880
Ann Oncol. 2007 Jun;18(6):1090-7
pubmed: 17355953
J Am Heart Assoc. 2020 May 18;9(10):e014949
pubmed: 32378443
J Pain Symptom Manage. 2006 Feb;31(2):140-7
pubmed: 16488347
JAMA. 2000 Nov 15;284(19):2476-82
pubmed: 11074777
J Am Coll Cardiol. 2021 Feb 2;77(4):501-505
pubmed: 33509401
Eur J Heart Fail. 2020 Dec;22(12):2327-2339
pubmed: 32892431
Circ J. 2019 Sep 25;83(10):2084-2184
pubmed: 31511439
BMC Cancer. 2019 Jan 14;19(1):63
pubmed: 30642289

Auteurs

Hiroki Kitakata (H)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Takashi Kohno (T)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.
Department of Cardiovascular Medicine, Kyorin University Faculty of Medicine, 6-20-2, Shinkawa, Mitaka, Tokyo, Japan.

Shun Kohsaka (S)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Daisuke Fujisawa (D)

Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Naomi Nakano (N)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Yasuyuki Shiraishi (Y)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Yoshinori Katsumata (Y)

Institute for Integrated Sports Medicine, Keio University School of Medicine, Tokyo, Japan.

Yuji Nagatomo (Y)

Department of Cardiology, National Defense Medical College, Saitama, Japan.

Shinsuke Yuasa (S)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Keiichi Fukuda (K)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH